Skip to main content
. 2022 Jul 29;9:916156. doi: 10.3389/fcvm.2022.916156

Figure 4.

Figure 4

Kaplan-Meier plots of cardiovascular survival probability (A) cardiovascular mortality rates of controls vs. patients treated with DOAC, (B) cardiovascular mortality rates of controls vs. patients treated with dipyridamole.